Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

BG Group, Shell, LSE, Glaxo, Songbird: U.K., Irish Stock Preview

April 7 (Bloomberg) -- The following is a list of companies that may have unusual share-price changes in U.K. and Irish markets. Stock symbols are in parentheses and prices are from the last market close.

The benchmark FTSE 100 Index rose 34.07 points, or 0.6 percent, to 6,041.13. Futures on the index rose less than 0.1 percent at 7:43 a.m. in London.

The FTSE All-Share Index gained 0.6 percent while Ireland’s ISEQ Index climbed 1.1 percent.

AstraZeneca Plc (AZN LN): The drugmaker said the U.S. Food and Drug Administration approved the orphan drug vandetanib for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body. The shares rose 0.7 percent to 2,927.5 pence.

BG Group Plc (BG/ LN): The Egyptian Natural Gas Holding Co., Egypt’s state-run company, reached an initial agreement to increase the price of gas exports to BG Group as global oil prices rise, Egyptian Oil Minister Abdalla Ghorab said. The shares rose 0.1 percent to 1,564 pence.

Carpetright Plc (CPR LN): The company said underlying pretax profit for the year ending April 30 will be “broadly in line” with the amount it earned two years ago after fragile consumer confidence led to a weak floorcoverings market. The shares lost 0.9 percent to 671.5 pence.

Electrocomponents Plc (ECM LN): The company said it expects annual sales to be “in excess of” 1 billion pounds ($1.63 billion) for the first time. The shares rose 0.9 percent to 268.2 pence.

GlaxoSmithKline Plc (GSK LN): The London-based drugmaker is among three potential buyers of Turkey’s Biofarma Pharmaceutical Industry Co., two people with knowledge of the matter said. The stock fell 0.4 percent to 1,213 pence.

Halfords Group Plc (HFD LN): The retailer said it plans to buy back as much as 75 million pounds of shares. The group said same-store sales in the fiscal year ended April rose 4.6 percent after being unchanged in the fourth quarter. The shares rose 3.5 percent to 368.6 pence.

Hays Plc (HAS LN): The staffing agency said comparable net fees for the fiscal third quarter rose 16 percent over the same period a year earlier. The shares rose 0.2 percent to 119.5 pence.

London Stock Exchange Group Plc (LSE LN): TMX Group Inc.’s buyout by LSE has a 40 percent chance of being approved after Australia set the precedent of rejecting a foreign bid for its exchange, National Bank Financial said. The stock gained 0.9 percent to 869 pence.

Royal Dutch Shell Plc (RDSA LN): Europe’s largest oil producer’s application to start shale-gas exploration in South Africa’s Karoo region should be terminated because it lacks sufficient information for regulators to assess it properly, Havemann Inc. attorneys said. The stock advanced 0.7 percent to 2,280 pence.

Songbird Estates Plc (SBD LN): The company that controls London’s Canary Wharf financial district said Qatar Holding LLC increased its stake to 27.68 percent. The shares climbed 2.4 percent to 149 pence.

To contact the reporter on this story: Blanche Gatt in London at bgatt@bloomberg.net

To contact the editor responsible for this story: Colin Keatinge at ckeatinge@bloomberg.net.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.